In type III CNV, what does "CME" stand for?

Cystoid Macular Edema (CME) is the correct term associated with type III choroidal neovascularization (CNV). This condition is characterized by the accumulation of fluid in the macula, leading to swelling and impaired vision. CME often occurs in conjunction with various retinal diseases, including age-related macular degeneration (AMD) and other forms of retinal pathology where CNV may develop.

CME is identified through specific clinical findings, such as the appearance of cystoid spaces within the inner layers of the retina. These fluid-filled cysts can lead to blurred vision and significant visual distortion, as they affect the fovea, which is responsible for sharp central vision. Understanding CME is crucial for diagnosing and managing patients with CNV, as treatment strategies may vary based on the presence and severity of edema.

The other options listed do not accurately describe the condition: Chronic Macular Edema refers to a broader category without the specific cystoid component, while Central Macular Exudate and Chronic Membranous Edema are not accepted medical terms that align with this clinical context. This highlights the importance of precise terminology in ophthalmology, particularly in discussing complications associated with CNV.